title: Loss of Syndecan-1 Abrogates the Pulmonary Protective Phenotype Induced by Plasma After Hemorrhagic Shock.
abstract: Syndecan-1 (Sdc1) is considered a biomarker of injury to the endothelial glycocalyx following hemorrhagic shock, with shedding of Sdc1 deleterious. Resuscitation with fresh frozen plasma (FFP) has been correlated with restitution of pulmonary Sdc1 and reduction of lung injury, but the precise contribution of Sdc1 to FFPs protection in the lung remains unclear. Human lung endothelial cells were used to assess the time and dose-dependent effect of FFP on Sdc1 expression and the effect of Sdc1 silencing on in vitro endothelial cell permeability and actin stress fiber formation. Wild-type and Sdc1 mice were subjected to hemorrhagic shock followed by resuscitation with lactated Ringers (LR) or FFP and compared with shock alone and shams. Lungs were harvested after 3 h for analysis of permeability, histology, and inflammation and for measurement of syndecan- 2 and 4 expression. In vitro, FFP enhanced pulmonary endothelial Sdc1 expression in time- and dose-dependent manners and loss of Sdc1 in pulmonary endothelial cells worsened permeability and stress fiber formation by FFP. Loss of Sdc1 in vivo led to equivalency between LR and FFP in restoring pulmonary injury, inflammation, and permeability after shock. Lastly, Sdc1 mice demonstrated a significant increase in pulmonary syndecan 4 expression after hemorrhagic shock and FFP-based resuscitation. Taken together, our findings support a key role for Sdc1 in modulating pulmonary protection by FFP after hemorrhagic shock. Our results also suggest that other members of the syndecan family may at least be contributing to FFP's effects on the endothelium, an area that warrants further investigation.
authors.affiliation: *Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland †Department of Anesthesia, University of Texas Health Science Center at Houston, Houston, Texas ‡Division of Respiratory Diseases, Children's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Feng
authors.initials: F
authors.lastname: Wu
authors.forename: Zhanglong
authors.initials: Z
authors.lastname: Peng
authors.forename: Pyong Woo
authors.initials: PW
authors.lastname: Park
authors.forename: Rosemary A
authors.initials: RA
authors.lastname: Kozar
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000378:metabolism* / Q000473:pathology; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D010949:Plasma; D012151:Resuscitation; D012771:Shock, Hemorrhagic / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D053668:Syndecan-1 / Q000235:genetics / Q000378:metabolism*
chemical_list: C508241:SDC1 protein, human; C508242:Sdc1 protein, mouse; D053668:Syndecan-1